Literature DB >> 12674765

Effect of ginsenoside Re on cardiomyocyte apoptosis and expression of Bcl-2/Bax gene after ischemia and reperfusion in rats.

Zhengxiang Liu1, Zhigang Li, Xiaochun Liu.   

Abstract

To observe the effect of ginsenoside Re on cardiomyocyte apoptosis and Bcl-2/Bax gene expression after ischemia (30 min) and reperfusion (6 h) in rats and to elucidate the possible mechanisms of ginsenoside Re on inhibition of cardiomyocyte apoptosis, the ischemia/reperfusion heart model was established by ligating the left anterior descending branch of coronary artery in Wistar rats. The apoptotic cardiomyocytes were confirmed by transmission electron microscopy and counted by in situ nick end labeling (TUNEL) method and light microscopy. The mRNA and protein expression of Bcl-2 and Bax genes were studied by in situ hybridization and immunohistochemical staining. Mean optical density (OD) value of the positive fields of mRNA and protein expression was quantitatively examined by image analysis system. The results were as follows: (1) The apoptotic cardiomyocytes were found in ischemic fields in the ischemia/reperfusion group and weren't observed in the sham-operation group by transmission electron microscopy; (2) The numbers of the apoptotic cells were 134.45 +/- 45.61/field in the ischemia/reperfusion group, and 90.66 +/- 19.22/field in the ginsenoside Re-treated group. The differences was significant between two groups (P < 0.01); (3) Gene expression of Bcl-2 and Bax were increased significantly in the ischemia/reperfusion group and ginsenoside Re-treated group when compared with the sham-operation group. There was no significant difference in the gene expression of Bcl-2 between the ginsenoside Re-treated group and ischemia/reperfusion group (P > 0.05), but gene expression of Bax was decreased significantly in the ginsenoside Re-treated group as compared with the ischemia/reperfusion group (P < 0.01). The ratio of Bcl-2/Bax was increased significantly in the ginsenoside Re-treated group when compared with the ischemia/reperfusion group and sham-operation group. These findings suggest that myocardial ischemia-reperfusion can induce cardiomyocyte apoptosis, and ginsenoside Re can significantly inhibit cardiomyocyte apoptosis induced by ischemia-reperfusion in rats. It is concluded that ginsenoside Re inhibits cardiomyocyte apoptosis by inhibiting expression of pro-apoptotic Bax gene and raising the ratio of Bcl-2/Bax.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12674765     DOI: 10.1007/BF02896771

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

Review 1.  Apoptosis in myocardial ischemia-reperfusion.

Authors:  R A Gottlieb; R L Engler
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

Review 2.  Cardiac myocyte apoptosis.

Authors:  S A Cook; P A Poole-Wilson
Journal:  Eur Heart J       Date:  1999-11       Impact factor: 29.983

Review 3.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

4.  Panax ginseng administration in the rat prevents myocardial ischemia-reperfusion damage induced by hyperbaric oxygen: evidence for an antioxidant intervention.

Authors:  R Maffei Facino; M Carini; G Aldini; F Berti; G Rossoni
Journal:  Planta Med       Date:  1999-10       Impact factor: 3.352

5.  BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.

Authors:  X M Yin; Z N Oltvai; S J Korsmeyer
Journal:  Nature       Date:  1994-05-26       Impact factor: 49.962

Review 6.  Life, death, and the pursuit of apoptosis.

Authors:  E White
Journal:  Genes Dev       Date:  1996-01-01       Impact factor: 11.361

7.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

Authors:  Z N Oltvai; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

8.  DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.

Authors:  A Strasser; A W Harris; T Jacks; S Cory
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

9.  Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex.

Authors:  S Jayanthi; X Deng; M Bordelon; M T McCoy; J L Cadet
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

10.  Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.

Authors:  E Yang; J Zha; J Jockel; L H Boise; C B Thompson; S J Korsmeyer
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

  10 in total
  10 in total

Review 1.  Therapeutic potential of ginseng in the management of cardiovascular disorders.

Authors:  Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 2.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

3.  Panax ginseng extract modulates oxidative stress, DNA fragmentation and up-regulate gene expression in rats sub chronically treated with aflatoxin B1 and fumonisin B 1.

Authors:  Aziza M Hassan; Sekena H Abdel-Aziem; Aziza A El-Nekeety; Mosaad A Abdel-Wahhab
Journal:  Cytotechnology       Date:  2014-04-19       Impact factor: 2.058

4.  Effects of Shenmai injection and its bioactive components following ischemia/reperfusion in cardiomyocytes.

Authors:  Li-Fang Ye; Ya-Ru Zheng; Li-Hong Wang
Journal:  Exp Ther Med       Date:  2015-07-28       Impact factor: 2.447

5.  Ginseng is useful to enhance cardiac contractility in animals.

Authors:  Jia-Wei Lin; Yih-Giun Cherng; Li-Jen Chen; Ho-Shan Niu; Chen Kuei Chang; Chiang-Shan Niu
Journal:  Biomed Res Int       Date:  2014-02-04       Impact factor: 3.246

6.  Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax.

Authors:  Liang Zhang; Jian Zhang; Qiguang Tong; Guannan Wang; Hongling Dong; Zhonglu Wang; Qi Sun; Hangyu Wu
Journal:  Exp Ther Med       Date:  2019-07-01       Impact factor: 2.447

Review 7.  Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury.

Authors:  Zhihan Chen; Jingping Wu; Sijing Li; Caijiao Liu; Yulan Ren
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

8.  Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA‑21 expression, Akt and the Bcl‑2/Bax pathway.

Authors:  Ning Ma; Jingyun Bai; Weihua Zhang; Hong Luo; Xin Zhang; Donghai Liu; Chenhui Qiao
Journal:  Mol Med Rep       Date:  2016-09-26       Impact factor: 2.952

9.  Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis.

Authors:  Bing Pang; Li-Wei Shi; Li-Juan Du; Yun-Chu Li; Mei-Zhen Zhang; Qing Ni
Journal:  BMC Complement Altern Med       Date:  2019-11-12       Impact factor: 3.659

Review 10.  Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: A systematic review.

Authors:  Mohammad Amjad Hossain; Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2022-01-19       Impact factor: 5.735

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.